Angiomax Generic From Hospira Might Launch At-Risk Launch In 2015
District Court upholds validity of TMC’s process patents for its anticoagulant but finds Hospira does not infringe them.
District Court upholds validity of TMC’s process patents for its anticoagulant but finds Hospira does not infringe them.